The value and throughput of rest thallium-201/stress technetium -99m sestamibi dual-isotope myocardial SPECT

Anadolu Kardiyoloji Dergisi

Volumn 4, Issue 2, 2004, Pages 161-168

  Okudan, Berna ^a,c   Smitherman, Thomas C ^b  

^a Training Hospital   (Turkey)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Dual isotope myocardial imaging TI 201 Tc 99m MIBI myocardial SPECT; Rest TI 201 stress Tc 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ARTICLE; ARTIFACT; CORONARY ARTERY DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG HALF LIFE; DRUG TISSUE LEVEL; GATED IMAGING; HEALTH CARE COST; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; NON INVASIVE MEASUREMENT; RADIATION ATTENUATION; RADIATION SCATTERING; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ARTERIOSCLEROSIS; EXERCISE TEST; HUMANS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES;

EID: 3042681446     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Atkins HL, Budinger TF, Lebowitz E, et al. Thallium-201 for medical use: Part 3: Human distribution and physical imaging properties. J Nucl Med 1977; 18: 133-40.
2. Krahwinkel W, Herzog H, Feinendegen LE. Pharmacokinetics of thallium-201 in normal individuals after routine myocardial scintigraphy. J Nucl Med 1988; 29:1582-86.
3. Gerson MC. Cardiac Nuclear Medicine, 3rd ed. McGraw Hill, USA: 1997, pp 9.
4. Garcia EV, Van Train K, Maddahi J. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med 1985; 26: 17-26.
5. Mahmarian JJ, Verani MS. Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease. Am J Cardiol. 1991; 67: 2D-11D.
6. Lemlek J, Heo J, Iskandrian AS. The clinical relevance of myocardial viability in patient management. Am Heart J 1992; 124: 1327-31.
7. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977; 55: 294-302.
8. Mettler AF, Guiberteau MJ. Essentials of nuclear medicine imaging. (3th edition) 1991; Philadelphia; WB Saunders Company: 95-131.
9. Imaging Guidelines for Nuclear Cardiology (Part 1,2). J Nuc Cardiol 2001, 8(Suppl): G5-G58.
10. Germano G, Erel J, Kiat H, Kavanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med 1997; 38: 749-54.
11. Maunoury C, Chen CC, Chua KB, Thompson CJ. Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT. J Nucl Med 1997; 38: 958-61.
12. Mochizuki T, Murase K, Fujiwara Y, et al. ECG-gated thallium-201 myocardial SPECT in patients with old myocardial infarction compared with ECG-gated blood pool SPECT. Ann Nucl Med 199 1;5: 47-51.
13. Berman DS, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J. Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med 1991; 21:190-212.
14. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 1991; 21: 173-81.
15. Mousa SA, Williams SJ, Sands H. Characterization of in vivo chemistry of cations in the heart. J Nucl Med 1987; 28:1351-7.
16. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988; 77: 491-8.
17. Canby RC, Silber S, Pohost GM. Relations of the myocardial imaging agents 99mTc-MIBI and 201Tl to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990; 81: 289-96.
18. Sinusas AJ, Shi Q, Vitols PJ, et al. Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size. Circulation 1993; 88: 2224-34.
19. Li QS, Solot G, Frank TL, Wagner HN Jr, Becker LC. Myocardial redistribution of technetium-99m-methox-yisobutyl isonitrile (SESTAMIBI). J Nucl Med 1990; 31: 1069-76.
20. Hachamovitch R. Clinical application of rest thallium-201/Stress technetium-99m sestamibi dual isotope myocardial perfusion single-photon emission computed tomography. Cardiol Rev 1999; 7: 83-91.
21. Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993; 22: 1455-64.
22. Berman DS, Kiat HS, Van Train KF, Germano G, Maddahi J, Friedman JD. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 1994;35: 681-8.
23. Weinmann P, Foult JM, Le Guludec D, et al. Dual-isotope myocardial imaging: feasibility, advantages and limitations. Preliminary report on 231 consecutive patients. Eur J Nucl Med 1994; 21:212-5.
24. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87: 1-20.
25. Kiat H, Germano G, Friedman J, et al. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. J Nucl Med 1994; 35: 542-8.
26. Loutfi I, Singh A. Comparison of single-tracer (technetium-99m-sestamibi) and dual-tracer (thallium-201 chloride and technetium-99m-sestamibi) protocols for identification of myocardial ischemia. Invest Radiol 1995; 30: 367-71.
27. Fukuoka S, Maeno M, Nakagawa S, Fukunaga T, Yamada H, Eto T. Feasibility of myocardial dual-isotope perfusion imaging combined with gated single photon emission tomography for assessing coronary artery disease. Nucl Med Commun 2002; 23:19-29.
28. Groutars RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 2000; 7: 333-41.
29. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002; 19: 823-9.
30. Paeng JC, Lee DS, Cheon GJ, Kim KB, Yeo JS, Chung JK, Lee MC. Consideration of perfusion reserve in viability assessment by myocardial Tl-201 rest-redistribution SPECT: a quantitative study with dual-isotope SPECT. J Nucl Cardiol 2002; 9:68-74.
31. Milan E, Giubbini R, Gioia G, Terzi A, Iskandrian AE. A cost-effective sestamibi protocol in the managed health care era. J Nucl Cardiol 1997; 4: 509-14.
32. Berman DS, Kiat H, Maddahi J. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime. Circulation 1991; 84 (Suppl): 17-21.
33. Kwok CG, Wu S, Tsang HP, Strauss HW. Feasibility of simultaneous dual-isotope myocardial perfusion acquisition using a lower dose of sestamibi. Eur J Nucl Med 1997; 24: 281-5.
34. Unlu M, Gunaydin S, Ilgin N, Inanir S, Gokcora N, Gokgoz L. Dual isotope myocardial perfusion SPECT in the detection of coronary artery disease: comparison of separate and simultaneous acquisition protocols. J Nucl Biol Med 1993; 37: 233-7.
35. Lowe VJ, Greer KL, Hanson MW, Jaszczak RJ, Coleman RE. Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images. J Nucl Med 1993; 34: 1998-2006.
36. Yang DC, Ragasa E, Gould L, et al. Radionuclide simultaneous dual-isotope stress myocardial perfusion study using the "three window technique". Clin Nucl Med 1993; 18: 852-7.
37. Nakamura M, Takeda K, Ichihara T. et al. Feasibility of simultaneous stress 99mTc-sestamibi/rest 201Tl dual-isotope myocardial perfusion SPECT in the detection of coronary artery disease. J Nucl Med 1999; 40: 895-903.
38. Knesaurek K, Machac J. Enhanced cross-talk correction technique for simultaneous dual-isotope imaging: a TL-201/Tc-99m myocardial perfusion SPECT dog study. Med Phys 1997; 24:1914-23.
39. Knesaurek K, Machac J. A transformation cross-talk technique for simultaneous dual radionuclide imaging: a myocardial perfusion 201Tl/99mTc sestamibi dog SPECT study. Br J Radiol 1999; 72: 872-81.
40. Hannequin P, Weinmann P, Mas J, Vinot S. Preliminary clinical results of photon energy recovery in simultaneous rest Tl-201/stress Tc-99m sestamibi myocardial SPECT. J Nucl Cardiol 2001; 8: 144-51.
41. Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 1993; 34: 601-8.
42. Tischler MD, Niggel JB, Battle RW, Fairbank JT, Brown KA. Validation of global and segmental left ventricular contractile function using gated planar technetium-99m sestamibi myocardial perfusion imaging. J Am Coll Cardiol 1994; 23:141-5.
43. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993; 34: 1871-6.
44. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29:69-77.
45. Germano G, Berman DS. On the accuracy and reproducibility of quantitative gated myocardial perfusion SPECT. J Nucl Med 1999; 40: 810-3.
46. Germano G, Berman DS. Quantitative gated SPECT. J Nucl Med 2001; 4: 528-9.
47. Tadamura E, Kudoh T, Motooka M, et al. Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging. J Am Coll Cardiol 1999; 33: 991-7.
48. Wadhwa SS, Mansberg R, Wilkinson D, Abbati D. Gated Tl-201 myocardial perfusion SPECT: application of energy window optimization. Clin Nucl Med 1999; 24: 479-82.
49. Mazzanti M, Germano G, Kiat H. et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996; 27:1612-20.
50. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-7.
51. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33:1925-30.
52. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992; 33: 505-11.
53. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1592-7.
54. Maes AF, Borgers M, Flameng W, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997; 29:62-8.
55. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Circulation 1994; 89: 578-87.
56. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96:2892-8.
57. Kiser JW, Drane WE, Mastin ST, Nicole MW. Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake. Clin Nucl Med 1998; 23: 432-6.
58. Takehana K, Ruiz M, Petruzella FD, Watson DD, Beller GA, Glover DK. Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis. J Nucl Cardiol 2001; 8: 40-8.